Wave Life Sciences WVE Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Research And Development Expense by Product | ||||||
| AATD Program | $1.75M+20.3% | $1.46M+50.5% | $967K-47.6% | $1.85M+27.7% | $1.45M-45.0% | |
| DMD Programs | $4.14M— | —— | —— | —— | $3.04M-21.8% | |
| HD Programs | $63K— | —— | —— | —— | $1.17M-60.4% | |
| INHBE Program | $4.84M-4.9% | $5.09M+11.2% | $4.57M+30.1% | $3.52M+38.4% | $2.54M-41.4% | |
| Other Research And Development Expenses Including PNPLA3Additional Preclinical Programs PRISM | $36.65M— | —— | —— | —— | $32.43M+16.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Wave Life Sciences break its business down?
- Wave Life Sciences (WVE) reports research and development expense by product across 5 parts — AATD Program, DMD Programs, HD Programs, INHBE Program and Other Research And Development Expenses Including PNPLA3Additional Preclinical Programs PRISM. Each is extracted from the segment footnotes and tracked over time.
- Where does Wave Life Sciences's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Wave Life Sciences's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
